Human Genome Sciences (HGSI) has the potential to be one of the biggest underdog wins of the year – and we’ve seen a lot: Vanda, JAZZ, DNDN. With the news today, fortunes are not only made, but lives of lupus patients gain some hope that a new targeted therapy is on the horizon. The disease is not another anti-cholesterol med or another abuse-resistant painkiller, but something that targets a HUGE unmet medical need. Truly remarkable and a great achievement.

So, who’s talking about HGSI’s success today?

• Human Genome Transforms Overnight With Lupus Success. [WSJ]

• Human Genome Science Triples on Success of Lupus Drug. [Bloomberg]

• Experimental drug helps lupus patients. [Reuters]

• What’s Next for High-Flying Human Genome Sciences? [Barron's]

• Health Buzz: Lupus Drug Sees Success in Trial and Other Health News. [USNews]

• Human Genome Sciences lupus drug met study goal. [Forbes]

• Lupus drug Benlysta shows promise, company says. [USA Today]

• HGS’s Lupus Drug Shows Promise in Latest Trials. [The Washington Post]

• Experimental Lupus Drug Benlysta Succeeds in Trial. [Attorney At Law]

• Lupus drug, Benlysta stood the clinical tests. [TopNews]

• New lupus drug to be tested. [Pharmacy Europe]

• Trial for New Lupus Treatment Is Called Promising. [The New York Times]

• Benlysta Effective in Some Lupus Sufferers. [BusinessWeek]

Congrats again…

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts